HUTCHMED (China) (HCM) Receivables (2016 - 2025)

HUTCHMED (China) has reported Receivables over the past 11 years, most recently at $178.5 million for Q4 2025.

  • Quarterly Receivables rose 9.25% to $178.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $178.5 million through Dec 2025, up 9.25% year-over-year, with the annual reading at $178.5 million for FY2025, 9.25% up from the prior year.
  • Receivables was $178.5 million for Q4 2025 at HUTCHMED (China), up from $163.4 million in the prior quarter.
  • Over five years, Receivables peaked at $178.5 million in Q4 2025 and troughed at $85.1 million in Q4 2021.
  • The 5-year median for Receivables is $145.4 million (2023), against an average of $134.2 million.
  • Year-over-year, Receivables surged 77.39% in 2021 and then increased 9.25% in 2025.
  • A 5-year view of Receivables shows it stood at $85.1 million in 2021, then rose by 16.11% to $98.8 million in 2022, then soared by 47.13% to $145.4 million in 2023, then increased by 12.44% to $163.4 million in 2024, then grew by 9.25% to $178.5 million in 2025.
  • Per Business Quant, the three most recent readings for HCM's Receivables are $178.5 million (Q4 2025), $163.4 million (Q4 2024), and $145.4 million (Q4 2023).